PACB - Pacific Biosciences of California, Inc.
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Valuation Measures
| Market Cap (intraday) 5 | 844.75M |
| Enterprise Value 3 | 857.78M |
| Trailing P/E | N/A |
| Forward P/E 1 | -9.86 |
| PEG Ratio (5 yr expected) 1 | -0.25 |
| Price/Sales (ttm) | 10.24 |
| Price/Book (mrq) | 16.58 |
| Enterprise Value/Revenue 3 | 10.40 |
| Enterprise Value/EBITDA 6 | -9.69 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.71 |
| 52-Week Change 3 | -27.31% |
| S&P500 52-Week Change 3 | 24.46% |
| 52 Week High 3 | 7.51 |
| 52 Week Low 3 | 4.37 |
| 50-Day Moving Average 3 | 4.96 |
| 200-Day Moving Average 3 | 5.53 |
Share Statistics
| Avg Vol (3 month) 3 | 1.58M |
| Avg Vol (10 day) 3 | 1.46M |
| Shares Outstanding 5 | 153.03M |
| Float | 149.42M |
| % Held by Insiders 1 | 4.18% |
| % Held by Institutions 1 | 74.12% |
| Shares Short (Nov 29, 2019) 4 | 20M |
| Short Ratio (Nov 29, 2019) 4 | 11.87 |
| Short % of Float (Nov 29, 2019) 4 | 14.19% |
| Short % of Shares Outstanding (Nov 29, 2019) 4 | 13.07% |
| Shares Short (prior month Oct 31, 2019) 4 | 20.07M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor (new per old) 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2018 |
| Most Recent Quarter (mrq) | Sep 30, 2019 |
Profitability
| Profit Margin | -139.22% |
| Operating Margin (ttm) | -116.08% |
Management Effectiveness
| Return on Assets (ttm) | -36.38% |
| Return on Equity (ttm) | -125.58% |
Income Statement
| Revenue (ttm) | 82.49M |
| Revenue Per Share (ttm) | 0.54 |
| Quarterly Revenue Growth (yoy) | 20.70% |
| Gross Profit (ttm) | 25.1M |
| EBITDA | -88.49M |
| Net Income Avi to Common (ttm) | -114.84M |
| Diluted EPS (ttm) | -0.76 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 49.2M |
| Total Cash Per Share (mrq) | 0.32 |
| Total Debt (mrq) | 62.24M |
| Total Debt/Equity (mrq) | 122.00 |
| Current Ratio (mrq) | 1.52 |
| Book Value Per Share (mrq) | 0.33 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -79.12M |
| Levered Free Cash Flow (ttm) | -23.6M |